Charles Fraley
Family Medicine · Murrieta, CANPI 1184892135
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 120 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 28.5% of the total. Reporting peaked in 2019 at $679 and has fallen 95.4% since, to $31 in 2023.
Across 120 payments — averaging $15.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$540
- Daiichi Sankyo Inc.$214
- Novo Nordisk$210
- Takeda Pharmaceuticals U.S.A., Inc.$152
- GSK$115
- Antares Pharma, Inc.$103
- plus $563 from 17 others
What the payments were for
- Food & beverage$1,86598%
- Education$302%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 37 | $540 |
| Daiichi Sankyo Inc. | 11 | $214 |
| Novo Nordisk | 9 | $210 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $152 |
| GSK | 5 | $115 |
| Antares Pharma, Inc. | 6 | $103 |
| Pfizer | 5 | $96 |
| Merck | 3 | $51 |
| Aytu Biopharma, Inc. | 3 | $47 |
| Johnson & Johnson | 3 | $41 |
| Abbott | 2 | $40 |
| Amgen | 2 | $39 |
| Astellas Pharma US Inc | 2 | $39 |
| Lilly USA, LLC | 3 | $35 |
| E.r. Squibb & Sons, L.L.C. | 2 | $26 |
| Nevro Corp. | 1 | $26 |
| Eisai Inc. | 2 | $25 |
| Hologic Sales And Service, LLC | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Boehringer Ingelheim | 1 | $18 |
| IBSA Pharma Inc. | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| AstraZeneca | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INJECTAFER$125
- Ozempic$102
How this compares
$1,895 in reported general payments places this provider in the 80th percentile of 10,533 family medicine providers in California.
Other family medicine in Murrieta
- Bridget BriggsMurrieta$116K
- Sherly SoleimanEncino$1.2M
- Pamela KushnerLos Angeles$1.2M
- Sujata NarayanStanford$1.2M
- Jeffrey UngerChino$906K
- Alexander RivkinLos Angeles$866K
- Scott HowellLos Angeles$793K
- Derrick ButlerLos Angeles$692K
- Sandra CalmanMontara$589K
- Anthony JonesOakland$377K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.